Plasma Fractionation Market Size by Application, Type, Regional, Industry
Statistics & Forecast 2021 - 2025
Global Plasma Fractionation market Size by Type, End User and Application: Global Opportunity
Analysis and Industry Forecast, 2020-2025. The base year considered for the study is 2020, and the
forecast has been provided for the period from 2020 to 2025.
Human blood plasma is natures raw material for dozens of life-saving treatments and medications.
By extracting the active ingredients and disinfection, people get related preparations from blood
plasma, which is called Plasma Fractionation. North America is the largest supplier of Plasma
Fractionation, with production revenue market share about 60%, and the sales market share is
44% in 2015. That is to say, there are a large number of exports in North America, while North
America also is the largest consumption region.
Japan has production revenue market share of 5% and sales revenue market share of 7% nearly in
2015. The local production can meet most local demand, and there is a small amount of imports.
Baxter, CSL, Grifols are the leaders of the industry, with 65% market share in 2015, and hold key
technologies and patents. Other manufactures’ products are used to meet local demand. With
further expanding market, there will be more players in the future.
According to this study Plasma Fractionation market will register a 10.6% CAGR in terms of
revenue, the global market size will reach US$ 52800 million by 2025, from US$ 28900 million in
2020. The research report offers an outlook of the attractiveness of the segments and regions,
which are formulated based on their growth rate (CAGR) and market size. The study report
includes the market restrictions and drivers, which may be analyzed from SWOT assessment of the
Plasma Fractionation market.
Rubix Market Research made available a report, which has all company profile the key companies
and brands and along with that the report also comprise